Found 0 matching trials
Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC PHASE2 The purpose of this research study is to determine how people with weakened...
Show More Location
University of Arizona Cancer Center
Learn More & Join Trial
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer PHASE2 The purpose of the study is to see if the combination of radiation therapy ...
Show More Status
Active Not Recruiting
Location
University of Colorado (Data Collection Only)
Learn More & Join Trial
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial) PHASE2 This phase II/III Expanded Lung-MAP treatment trial compares the effect of ...
Show More Location
Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis
Learn More & Join Trial
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) PHASE2 The purpose of this study is to evaluate the experimental immunotherapy age...
Show More Location
Multiple Locations
Learn More & Join Trial
Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma PHASE2 This phase II trial studies how well cemiplimab works in treating patients ...
Show More Location
Northwestern University
Learn More & Join Trial
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma PHASE2 This phase II trial compares the effect of chemotherapy (carboplatin and pa...
Show More Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Learn More & Join Trial
Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer PHASE2 This phase II trial tests how well a fixed dose combination (FDC) of cemipl...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma PHASE1 This phase I trial studies the best dose and side effects of the VSV-hIFNβ-...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma PHASE1 This phase I trial studies the best dose and side effects of recombinant ve...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma PHASE1 The goal of this clinical research study is to determine if Cemiplimab-rwlc...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial